Stand Up To Cancer (SU2C), the Melanoma Research Alliance (MRA) and SU2C’s scientific partner, the American Association for Cancer Research (AACR), today announced a new Dream Team dedicated to melanoma research. Jeffrey M. Trent, Ph.D., and Patricia M. LoRusso, D.O., will lead the Dream Team project entitled “Personalized Medicine for Patients with BRAF Wild-Type (BRAFwt) Cancer.”…Dream Team members come from the following institutions: Translational Genomic Research Institute, Karmanos Cancer Institute, Mayo Clinic, Michigan State University College of Human Medicine, Scripps Research Institute & Scripps Health…Additional coverage: Arizona Republic, MSU News
AACR, 12/2011
Tags: Cancer, Mayo Clinic Arizona